Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01219491 · ClinicalTrials.gov registry record
Egg Donor Recipient Characteristics Preferences
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 131
- Enrollment target
NCT01219491: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT01219491 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01219491 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
Study Summary
To identify the characteristics in an egg donor that are important to a recipient and to see if those characteristics change over time.
Primary Outcome
To identify the characteristics of donors which are important to recipients and whether their importance changes over time.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2007-12 |
| Est. Completion | 2011-11 |
What the finished NCT01219491 record still lists
NCT01219491 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01219491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01219491 about?
NCT01219491 is a clinical study titled "Egg Donor Recipient Characteristics Preferences". To identify the characteristics in an egg donor that are important to a recipient and to see if those characteristics change over time.
What is the current status of trial NCT01219491?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2007-12. Estimated completion is 2011-11.
Who is sponsoring clinical trial NCT01219491?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia